TWi Pharmaceuticals Inc (4180):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TWi Pharmaceuticals Inc (4180) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8218
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TWi Pharmaceuticals Inc (TWi), formerly Anchen Pharmaceuticals (Taiwan) Inc is a technology based pharmaceutical company that manufactures high barrier generics drugs. The company provides products such as donepezil hydrochloride tablets, hydroquinone cream, hydroquinone time release cream, megestrol acetate oral suspension and nifedipine extended-release tablets, among others. Its drugs consists of oral controlled release dosage form, non-oral parental and transdermal products, novel drug delivery systems, polymeric oral delivery systems, and others. TWi develops oral high barrier generic prescription products for muscle relaxants, hypertension, vasospatic agina, anorexia, cachexia, alzheimar’s diseases, and others. The company operates in Taiwan. TWi is headquartered in Taipei, Taiwan.

TWi Pharmaceuticals Inc (4180) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TWi Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TWi Pharma Enters into Agreement with Intech Biopharm 11
Licensing Agreements 12
Castle Creek Pharma Enters into Licensing Agreement with TWi Biotechnology 12
Equity Offering 13
TWi Biotechnology to Raise USD17.5 Million in IPO 13
TWi Pharma Raises USD87 Million in Public Offering of Global Depository Receipts 14
TWi Pharma Completes IPO 15
TWi Pharma Announces Private Placement Of Shares For US$11 Million 16
Acquisition 17
TWi Pharmaceutical Cayman to Sell its Stake in Hainan-Based Pharmaceuticals Company for USD28.6 Million 17
TWi Pharma to Acquire 50% Stake in Hainan Visum Pharma 18
TWi Pharma Acquires U-Liang Pharma 19
TWi Pharmaceuticals Inc – Key Competitors 20
TWi Pharmaceuticals Inc – Key Employees 21
TWi Pharmaceuticals Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TWi Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
TWi Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TWi Pharma Enters into Agreement with Intech Biopharm 11
Castle Creek Pharma Enters into Licensing Agreement with TWi Biotechnology 12
TWi Biotechnology to Raise USD17.5 Million in IPO 13
TWi Pharma Raises USD87 Million in Public Offering of Global Depository Receipts 14
TWi Pharma Completes IPO 15
TWi Pharma Announces Private Placement Of Shares For US$11 Million 16
TWi Pharmaceutical Cayman to Sell its Stake in Hainan-Based Pharmaceuticals Company for USD28.6 Million 17
TWi Pharma to Acquire 50% Stake in Hainan Visum Pharma 18
TWi Pharma Acquires U-Liang Pharma 19
TWi Pharmaceuticals Inc, Key Competitors 20
TWi Pharmaceuticals Inc, Key Employees 21
TWi Pharmaceuticals Inc, Other Locations 22
TWi Pharmaceuticals Inc, Subsidiaries 22

List of Figures
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TWi Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TWi Pharmaceuticals Inc (4180):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inchcape plc (INCH):企業の財務・戦略的SWOT分析
    Inchcape plc (INCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Biocartis Group NV (BCART) – Product Pipeline Analysis, 2018 Uate
    Summary Biocartis Group NV (Biocartis) is a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key …
  • Trinity Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Trinity Health (Trinity) formerly known as CHE Trinity Health, is a national Catholic health care organization that provides health care solutions in the US. It operates through a network of hospitals, health care services, and advocate partnerships at community, regional, and national level …
  • Jardine Lloyd Thompson Group plc:企業のM&A・事業提携・投資動向
    Jardine Lloyd Thompson Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Jardine Lloyd Thompson Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Genpact Limited:企業のM&A・事業提携・投資動向
    Genpact Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genpact Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Dermalogica, Inc.:企業の戦略・SWOT・財務情報
    Dermalogica, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dermalogica, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • St Ives plc (SIV):企業の財務・戦略的SWOT分析
    St Ives plc (SIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Permasteelisa S.p.A.:企業の戦略・SWOT・財務情報
    Permasteelisa S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Permasteelisa S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Abu Dhabi Commercial Bank P.J.S.C.:企業の戦略・SWOT・財務情報
    Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • The Royal Bank Of Scotland Group Plc:企業の戦略・SWOT・財務分析
    The Royal Bank Of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report Summary The Royal Bank Of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Wood Group Mustang Inc:企業の戦略的SWOT分析
    Wood Group Mustang Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • CITGO Petroleum Corp:企業の戦略的SWOT分析
    CITGO Petroleum Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • OSRAM Licht AG:企業のM&A・事業提携・投資動向
    OSRAM Licht AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's OSRAM Licht AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Msc Industrial Direct Co., Inc.:企業の戦略・SWOT・財務分析
    Msc Industrial Direct Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Msc Industrial Direct Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Johnson & Johnson:企業の戦略・SWOT・財務情報
    Johnson & Johnson - Strategy, SWOT and Corporate Finance Report Summary Johnson & Johnson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Shionogi & Co Ltd (4507):企業の財務・戦略的SWOT分析
    Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Krka, d. d., Novo mesto:企業の戦略・SWOT・財務分析
    Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report Summary Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Quantum Fuel Systems LLC:企業の戦略的SWOT分析
    Quantum Fuel Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Versartis Inc (VSAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Versartis Inc (Versartis) is a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of endocrine disorders. The company’s lead product candidate include somavaratan (VRS-317) is a recombinant human growth hormone (GHD) that is designed to reduc …
  • Nexstim Plc (NXTMH):企業の財務・戦略的SWOT分析
    Nexstim Plc (NXTMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆